choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Amgen Assets

Amgen Assets Newsletter
  • aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635 05 Sep 2025 18:00 GMT

    … -Clinical Development at Aptevo Therapeutics (Nasdaq: APVO), during which she led … partnerships and out-licensing of assets, and helped position ZymoGenetics for … of Merck Research Laboratories and Amgen (Nasdaq: AMGN). BriaCell also announces that its …

  • Is Amgen Stock Underperforming the S&P 500? 02 Sep 2025 23:00 GMT

    Headquartered in Thousand Oaks, California, Amgen Inc. (AMGN) discovers, develops, … to acquire promising pipeline assets that could drive long- … com On August 5, Amgen’s Q2 fiscal 2025 earnings … Market focus shifted to Amgen’s experimental weight-loss therapy …

  • BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up 25 Aug 2025 18:22 GMT

    … worldwide sales, excluding China, of Amgen Inc.’s AMGN Imdelltra (tarlatamab … other assets under the terms of the existing collaboration with Amgen, including … ) broadened the approved use of Amgen’s Repatha (evolocumab) to include …

  • Weight-Loss Wasteland: 5 Obesity Assets That Failed 25 Aug 2025 04:32 GMT

    … reason for this fanfare. Amgen itself has pushed MariTide hard … and a number of preclinical assets,” Bradner said. AMG 786, … investors had been expecting. Amgen crashed 11% in the aftermath … only partially rebounded. Still, Amgen is moving forward with MariTide …

  • Amgen Stock Sinks As Market Eyes MariTide's Next Move 06 Aug 2025 18:37 GMT

    … Sued By Eli Lilly, Amgen Over Drug Discount Program Product … the strong quarterly performance, Amgen raised fiscal year 2025 … Amgen has had meaningful clinical and commercial success with assets … reiterate our Outperform rating.” Amgen has some near-term …

  • Uncovering Potential: Amgen's Earnings Preview 04 Aug 2025 14:47 GMT

    … Unveiling the Story Behind Amgen Amgen is a leader in … Otezla for inflammatory diseases. Amgen introduced its first cancer … portfolio. Understanding the Numbers: Amgen's Finances Market … equity capital. Return on Assets (ROA): Amgen's financial …

  • Multispecific Antibodies Market Soars with Bispecific & Trispecific Therapeutics Assets in High Demand 25 Jul 2025 11:25 GMT

    … Big Pharma Investment: Regeneron, Roche, Amgen, AstraZeneca, Innovent, Zymeworks, and … Landscape Industry leaders include Roche, Amgen, Regeneron, Innovent, Zymeworks, Merus … filing patents and advancing multispecific assets through trial phases. Startups …

  • What Analysts Are Saying About Amgen Stock 21 Jul 2025 22:03 GMT

    … how financial experts perceive Amgen. The following summary outlines … on Amgen analyst ratings. Get to Know Amgen Better Amgen is … Otezla for inflammatory diseases. Amgen introduced its first cancer … equity capital. Return on Assets (ROA): Amgen's ROA …

  • Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Call Transcript 02 May 2025 13:09 GMT

    … advance key late-stage pipeline assets, including MariTide and Olpasiran. We … amp;A Session Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) We may use … 2025 Earnings Call. Follow Amgen Inc (NASDAQ:AMGN) Follow Amgen Inc (NASDAQ:AMGN) We may use …

  • Where Amgen Stands With Analysts 24 Jun 2025 20:58 GMT

    … on Amgen analyst ratings. Get to Know Amgen Better Amgen is … biosimilar portfolio. Breaking Down Amgen's Financial Performance … capital. Return on Assets (ROA): Amgen's ROA … demonstrates effective utilization of assets and strong financial performance. …

Satisfied with the content?

Continue to create your account.